Active Biotech AB (publ) (LON: 0GQU)
London
· Delayed Price · Currency is GBP · Price in SEK
0.114
0.00 (0.00%)
At close: Jan 21, 2025
Active Biotech AB Statistics
Total Valuation
Active Biotech AB has a market cap or net worth of GBP 9.79 million. The enterprise value is 9.48 million.
Market Cap | 9.79M |
Enterprise Value | 9.48M |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
Earnings Date | Feb 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +29.63% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 839.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 110.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.10 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 1.36.
Current Ratio | 0.93 |
Quick Ratio | 0.92 |
Debt / Equity | 1.36 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -178.08 |
Financial Efficiency
Return on equity (ROE) is -3,081.48% and return on invested capital (ROIC) is -662.25%.
Return on Equity (ROE) | -3,081.48% |
Return on Assets (ROA) | -181.44% |
Return on Capital (ROIC) | -662.25% |
Revenue Per Employee | n/a |
Profits Per Employee | -510,037 |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.49 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 53,605 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.12M |
Pretax Income | -3.06M |
Net Income | -3.06M |
EBITDA | -3.00M |
EBIT | -3.12M |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 456,090 in cash and 139,770 in debt, giving a net cash position of 316,321.
Cash & Cash Equivalents | 456,090 |
Total Debt | 139,770 |
Net Cash | 316,321 |
Net Cash Per Share | n/a |
Equity (Book Value) | 102,988 |
Book Value Per Share | 0.00 |
Working Capital | -58,850 |
Cash Flow
Operating Cash Flow | -2.91M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Active Biotech AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -29.63% |
Shareholder Yield | -29.63% |
Earnings Yield | -31.25% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |